Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 115

1.

Renal dysfunction after liver transplantation: effect of donor type.

Kollmann D, Neong SF, Rosales R, Hansen BE, Sapisochin G, McCluskey S, Bhat M, Cattral MS, Lilly L, McGilvray ID, Ghanekar A, Grant DR, Selzner M, Wong FSH, Selzner N.

Liver Transpl. 2020 Mar 19. doi: 10.1002/lt.25755. [Epub ahead of print]

PMID:
32189415
2.

Normothermic Ex Vivo Liver Perfusion Prevents Intrahepatic Platelet Sequestration After Liver Transplantation.

Kollmann D, Linares-Cervantes I, Ganesh S, Rosales R, Hamar M, Goto T, Urbanellis P, Tessandier N, Boilard E, Bruguera C, Wiebe A, Bartczak A, Yip P, Adeyi O, Selzner M, Selzner N.

Transplantation. 2020 Feb 21. doi: 10.1097/TP.0000000000003194. [Epub ahead of print]

PMID:
32091485
3.

Liver transplantation for unresectable colorectal liver metastasis: Who will get the benefit?

Goto T, Selzner M.

Am J Transplant. 2020 Feb;20(2):331-332. doi: 10.1111/ajt.15735. Epub 2019 Dec 28. No abstract available.

PMID:
31833650
4.

What Is Hot and New in Basic and Translational Science in Liver Transplantation in 2019? Report of the Basic and Translational Research Committee of the International Liver Transplantation Society.

Taner T, Martins PN, Ling Q, Ng KT, Huang KT, Eymard C, Bhat M, Bonaccorsi-Riani E, Mas VR, Selzner M, Ekser B.

Transplantation. 2020 Mar;104(3):516-521. doi: 10.1097/TP.0000000000003058.

PMID:
31815901
5.

Normothermic ex-vivo kidney perfusion improves early DCD graft function compared to hypothermic machine perfusion and static cold storage.

Urbanellis P, Hamar M, Kaths JM, Kollmann D, Linares I, Mazilescu L, Ganesh S, Wiebe A, Yip PM, John R, Konvalinka A, Mucsi I, Ghanekar A, Bagli DJ, Robinson LA, Selzner M.

Transplantation. 2019 Nov 20. doi: 10.1097/TP.0000000000003066. [Epub ahead of print]

PMID:
31815900
6.

Reply.

Linares-Cervantes I, Selzner M.

Liver Transpl. 2019 Aug;25(8):1284. doi: 10.1002/lt.25576. Epub 2019 May 29. No abstract available.

PMID:
31140719
7.

Predictor parameters of liver viability during porcine normothermic ex situ liver perfusion in a model of liver transplantation with marginal grafts.

Linares-Cervantes I, Echeverri J, Cleland S, Kaths JM, Rosales R, Goto T, Kollmann D, Hamar M, Urbanellis P, Mazilescu L, Ganesh S, Adeyi OA, Yip P, Goryńska P, Bojko B, Goryński K, Grant DR, Selzner N, Wąsowicz M, Selzner M.

Am J Transplant. 2019 Nov;19(11):2991-3005. doi: 10.1111/ajt.15395. Epub 2019 May 28.

PMID:
31012532
8.

Impact of Different Clinical Perfusates During Normothermic Ex Situ Liver Perfusion on Pig Liver Transplant Outcomes in a DCD Model.

Linares-Cervantes I, Kollmann D, Goto T, Echeverri J, Kaths JM, Hamar M, Urbanellis P, Mazilescu L, Rosales R, Bruguera C, Oquendo F, Ganesh S, Adeyi OA, Yip P, Selzner N, Selzner M.

Transplant Direct. 2019 Mar 4;5(4):e437. doi: 10.1097/TXD.0000000000000876. eCollection 2019 Apr.

9.

The Impact of Preexisting and Post-transplant Diabetes Mellitus on Outcomes Following Liver Transplantation.

Aravinthan AD, Fateen W, Doyle AC, Venkatachalapathy SV, Issachar A, Galvin Z, Sapisochin G, Cattral MS, Ghanekar A, McGilvray ID, Selzner M, Grant DR, Selzner N, Lilly LB, Renner EL, Bhat M.

Transplantation. 2019 Dec;103(12):2523-2530. doi: 10.1097/TP.0000000000002757.

PMID:
30985734
10.

What Is Hot and New in Basic Science in Liver Transplantation in 2018? Report of the Basic Science Committee of the International Liver Transplantation Society.

Martins PN, Selzner M, Dayangac M, Ling Q, Ng KT, Huang KT, Taner T, Mas VR, Ekser B.

Transplantation. 2019 Apr;103(4):654-659. doi: 10.1097/TP.0000000000002617. No abstract available.

PMID:
30801512
11.

Live donor liver transplantation for patients with hepatocellular carcinoma offers increased survival vs. deceased donation.

Goldaracena N, Gorgen A, Doyle A, Hansen BE, Tomiyama K, Zhang W, Ghanekar A, Lilly L, Cattral M, Galvin Z, Selzner M, Bhat M, Selzner N, McGilvray I, Greig PD, Grant DR, Sapisochin G.

J Hepatol. 2019 Apr;70(4):666-673. doi: 10.1016/j.jhep.2018.12.029. Epub 2019 Jan 8.

PMID:
30630009
12.

Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.

Doyle A, Gorgen A, Muaddi H, Aravinthan AD, Issachar A, Mironov O, Zhang W, Kachura J, Beecroft R, Cleary SP, Ghanekar A, Greig PD, McGilvray ID, Selzner M, Cattral MS, Grant DR, Lilly LB, Selzner N, Renner EL, Sherman M, Sapisochin G.

J Hepatol. 2019 May;70(5):866-873. doi: 10.1016/j.jhep.2018.12.027. Epub 2019 Jan 5.

PMID:
30615906
13.

Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis.

Galvin Z, Rajakumar R, Chen E, Adeyi O, Selzner M, Grant D, Sapisochin G, Greig P, Cattral M, McGilvray I, Ghanekar A, Selzner N, Lilly L, Patel K, Bhat M.

Liver Transpl. 2019 Jan;25(1):56-67. doi: 10.1002/lt.25338.

14.

Donor kidney volume measured by computed tomography is a strong predictor of recipient eGFR in living donor kidney transplantation.

Al-Adra DP, Lambadaris M, Barbas A, Li Y, Selzner M, Singh SK, Famure O, Kim SJ, Ghanekar A.

World J Urol. 2019 Sep;37(9):1965-1972. doi: 10.1007/s00345-018-2595-x. Epub 2018 Dec 6.

PMID:
30523400
15.

Reply.

Kollmann D, Goldaracena N, Selzner M.

Liver Transpl. 2019 Feb;25(2):341. doi: 10.1002/lt.25385. No abstract available.

16.

Steatosis in Liver Transplantation: Current Limitations and Future Strategies.

Linares I, Hamar M, Selzner N, Selzner M.

Transplantation. 2019 Jan;103(1):78-90. doi: 10.1097/TP.0000000000002466. Review.

PMID:
30418431
17.

Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations.

MacParland SA, Liu JC, Ma XZ, Innes BT, Bartczak AM, Gage BK, Manuel J, Khuu N, Echeverri J, Linares I, Gupta R, Cheng ML, Liu LY, Camat D, Chung SW, Seliga RK, Shao Z, Lee E, Ogawa S, Ogawa M, Wilson MD, Fish JE, Selzner M, Ghanekar A, Grant D, Greig P, Sapisochin G, Selzner N, Winegarden N, Adeyi O, Keller G, Bader GD, McGilvray ID.

Nat Commun. 2018 Oct 22;9(1):4383. doi: 10.1038/s41467-018-06318-7.

18.

Living Donor Liver Transplantation Using Selected Grafts With 2 Bile Ducts Compared With 1 Bile Duct Does Not Impact Patient Outcome.

Kollmann D, Goldaracena N, Sapisochin G, Linares I, Selzner N, Hansen BE, Bhat M, Cattral MS, Greig PD, Lilly L, McGilvray ID, Ghanekar A, Grant DR, Selzner M.

Liver Transpl. 2018 Nov;24(11):1512-1522. doi: 10.1002/lt.25197.

19.

Splenectomy as Flow Modulation Strategy and Risk Factors of De Novo Portal Vein Thrombosis in Adult-to-Adult Living Donor Liver Transplantation.

Linares I, Goldaracena N, Rosales R, Maza L, Kaths M, Kollmann D, Echeverri J, Selzner N, McCluskey SA, Sapisochin G, Lilly LB, Greig P, Bhat M, Ghanekar A, Cattral M, McGilvray I, Grant D, Selzner M.

Liver Transpl. 2018 Sep;24(9):1209-1220. doi: 10.1002/lt.25212.

20.

Live donor liver transplantation with older donors: Increased long-term graft loss due to HCV recurrence.

Goldaracena N, Barbas AS, Galante A, Sapisochin G, Al-Adra D, Selzner N, Galvin Z, Cattral MS, Greig PD, Lilly L, Bhat M, McGilvray ID, Ghanekar A, Levy G, Grant DR, Selzner M.

Clin Transplant. 2018 Aug;32(8):e13304. doi: 10.1111/ctr.13304. Epub 2018 Jul 16.

PMID:
29947154

Supplemental Content

Loading ...
Support Center